Treatment with the therapy, which is a combination of two monoclonal antibodies -- Casirivimab and Imdevimab -- was touted as a game changer with its better hold on the deadly Covid pandemic by Indian hospitals.
Mumbai: The Central Drugs Standards Control Organisation (CDSCO) on Wednesday gave Roche India emergency use authorisation (EUA) for its antibody cocktail jab of Casirivimab and Imdevimab. The Casirivimab-Imdevimab injection is…
Copyright © 2024 - Odisha Television Limited All Rights Reserved.